FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: IDIX

Sort
E.g., 2013-06-19
E.g., 2013-06-19
Enter a comma separated list of user names.

Idenix Pharmaceuticals, Inc (NASDAQ:IDIX) is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and Europe. Idenix Pharmaceuticals, Inc witnessed volume of 9.23 million shares during last trade however it holds an average trading capacity of 2.75 million shares.

Idenix Pharmaceuticals, Inc (NASDAQ:IDIX) witnessed volume of 8.30 million shares during last trade however it holds an average trading capacity of 1.28 million shares. IDIX last trade opened at $9.71 reached intraday low of $9.21 and went +24.22% up to close at $12.00.

Crown Equity Holdings Inc., (CRWE)

Crown Equity Holdings Inc. (CRWE.OB) announced that it has launched CRWE Tube, www.crwetube.com, a video sharing site that allows billions of people around the world to upload watch and share original videos.

Tags:

Idenix Pharmaceuticals, Inc (NASDAQ:IDIX) is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and Europe. Idenix Pharmaceuticals, Inc witnessed volume of 13.11 million shares during last trade however it holds an average trading capacity of 910,941 shares.

Idenix Pharmaceuticals, Inc (NASDAQ:IDIX) is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and Europe. Idenix Pharmaceuticals, Inc achieved its new 52 week high price of $10.39 where it was opened at $9.77 up 2.61 points or +37.02% by closing at $9.66.

AYI, Acuity Brands, Inc.

** On its first quarter fiscal 2012, AYI posted net sales of $474.3 million, an increase of $49.3 million, or approximately 12%, compared with the year-ago period.

Team, Inc., (NYSE:TISI) reported second quarter net income available to common shareholders of $10.3 million ($0.50 per diluted share), an increase of $2.3 million, or 28%, compared to the second quarter of last year. Revenues for the second quarter were $158.3 million, an increase of $25.1 million, or 19%, compared to the second quarter of last year.

Tags:

Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) witnessed volume of 4.66 million shares during last trade however it holds an average trading capacity of 1.02 million shares. IDIX last trade opened at $6.67 reached intraday low of $6.55 and went -6.83% down to close at $7.09.

Read Full Article and Disclaimer at: http://crwewallstreetnewsalert.com/?p=6943

Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) witnessed volume of 4.66 million shares during last trade however it holds an average trading capacity of 1.02 million shares. IDIX last trade opened at $6.67 reached intraday low of $6.55 and went -6.83% down to close at $7.09.

Read Full Article and Disclaimer at: http://crwewallstreetnewsalert.com/?p=6943

Pages

ADVERTISE WITH US